Bayer CropScience is currently trading at Rs. 748.55, up by 33.60 points or 4.70% from its previous closing of Rs. 714.95 on the BSE.
The scrip opened at Rs. 738.95 and has touched a high and low of Rs. 763.70 and Rs. 738.95 respectively. So far 3,662 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 999.00 on 01-Apr-2011 and a 52 week low of Rs. 655.00 on 10-Feb-2011.
Last one week high and low of the scrip stood at Rs. 763.70 and Rs. 686.15 respectively. The current market cap of the company is Rs. 2,956.00 crore.
The promoters holding in the company stood at 71.11% while Institutions and Non-Institutions held 15.28% and 13.61% respectively.
Bayer CropScience has received advance payment amounting to Rs 260 crore for the proposed sale of land and buildings situated at Kolshet Road, Balkum village in Thane. The company has received the amount pursuant to the exclusive arrangement entered on March 31, 2011 with Agile Real Estate.
However, the conveyance, transfer, sale and possession of the said property will be completed at a future date, subject to relevant approvals and permissions from the Government and other statutory bodies, as may be deemed necessary and on receipt of sale consideration as may be finally determined.
Bayer CropScience is engaged in manufacturing of crop protection products, non agricultural pest-control, seeds and plant biotechnology.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: